The NIH has awarded $8.3 million to a consortium of investigators, lead by Hans Herfarth, MD, PhD, Professor of Medicine in the Division of Gastroenterology & Hepatology, for the investigation of the clinical efficacy of methotrexate in patients with active ulcerative colitis.